Trials / Sponsors / Frontera Therapeutics
Frontera Therapeutics
Industry · 7 registered clinical trials — 7 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa X-Linked Retinitis Pigmentosa (XLRP) | Phase 1 / Phase 2 | 2024-04-01 |
| Recruiting | Gene Therapy for DME Diabetic Macular Edema | Phase 1 / Phase 2 | 2023-11-15 |
| Recruiting | Gene Therapy(FT-003) for Wet AMD Neovascular Age-related Macular Degeneration | Phase 1 / Phase 2 | 2023-08-15 |
| Recruiting | Gene Therapy for Diabetic Macular Edema Diabetic Macular Edema | Phase 1 | 2023-05-19 |
| Not Yet Recruiting | Gene Therapy for Wet AMD Neovascular Age-related Macular Degeneration | Phase 1 | 2023-05-01 |
| Recruiting | Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa X-Linked Retinitis Pigmentosa | EARLY_Phase 1 | 2023-02-01 |
| Recruiting | Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy Biallelic RPE65 Mutation-associated Retinal Dystrophy | Phase 1 / Phase 2 | 2022-11-30 |